NEW YORK (GenomeWeb News) – Qlucore has signed a distribution agreement with Novo Newton Scientific that allows the latter to market Qlucore's Omics Explorer software to pharmaceutical and biotechnology companies in Ireland, Spain, Italy, and South Africa.

Qlucore President Carl-Johan Ivarsson said that the arrangement with Novo Newton will increase the firm's market presence.

Tom Nugent, Novo Newton's CFO, added, "The amount of genomic data is growing very quickly, and there is strong demand for high quality solutions such as Qlucore."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.